Literature DB >> 19604605

Synthesis and characterization of the Zn(II) and Cu(II) piperidinyl isoeuxanthone complexes: DNA-binding and cytotoxic activity.

Hui-Fang Wang1, Rui Shen, Ning Tang.   

Abstract

Two new complexes ZnL(2)x2H(2)O (1) and CuL(2)x2H(2)O (2) (HL=1-hydroxy-6-(2-(1-piperidinyl)ethoxy)xanthone) have been synthesized and characterized. Their interactions with calf thymus DNA (ct DNA) were investigated by absorption spectroscopy, fluorescence spectroscopy, ethidium bromide (EB) displacement experiments, circular dichroism spectroscopy and viscosity measurements. Experimental results suggested that there were intercalative interactions of the complexes with DNA. The binding affinity of complex 2 was higher than that of 1. In addition, the cytotoxic effects of both complexes were evaluated with lung adenocarcinoma (GLC-82), esophagus squamous cancer (ECA109) and human gastric cancer (SGC7901) cells using MTT assay. Both were potent exhibiting significant cytotoxicity in vitro.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604605     DOI: 10.1016/j.ejmech.2009.06.019

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Spectroscopic and molecular modeling based approaches to study on the binding behavior of DNA with a copper (II) complex.

Authors:  Fatemeh Vahdati Rad; Mohammad Reza Housaindokht; Razieh Jalal; Hossein Eshtiagh Hosseini; Asma Verdian Doghaei; Sadegh Sadeghi Goghari
Journal:  J Fluoresc       Date:  2014-05-28       Impact factor: 2.217

2.  DNA binding property and antitumor evaluation of xanthone with dimethylamine side chain.

Authors:  Rui Shen; Weihua Wang; Gengliang Yang
Journal:  J Fluoresc       Date:  2014-04-06       Impact factor: 2.217

3.  The crucial role of divalent metal ions in the DNA-acting efficacy and inhibition of the transcription of dimeric chromomycin A3.

Authors:  Chun-Wei Hsu; Show-Mei Chuang; Wen-Ling Wu; Ming-Hon Hou
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.